Article Search

Ponsegromab for the Treatment of Cancer Cachexia

Growth differentiation factor 15 seems to be a driver in cancer cachexia. Ponsegromab targets this pathway and shows a meaningful improvement in weight, appetite and activity level in patients with a high level of this protein. It is fantastic to see a study like this and I’m excited to use this drug when available.

Read More »

Keyword Search

  • Cancer Types

  • Month Contributed

  • Show FCS Articles Only

  • Sort Order

  • Number of Posts